PRCT PROCEPT BioRobotics Corporation Common Stock
XNAS
19.20
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
PRCT
$19.20
—
Key stats
$19.20
- 52-Week Range
- $16.66 – $38.11
- YTD
- -37.58%
- IV Rank (30D)
- 66.33
- Straddle Price
- $3.53
- P/C Vol Ratio
- 0.34
- Market Cap
- $1.1B
- Open
- $20.33
- Day Range
- $18.90 – $20.37
- Volume
- 856,458
- Prev Close
- $20.30
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.05% |
| Beta vs SPY | 1.21 |
| Cost of Equity (CAPM) | 11.69% (VRP-adj) |
| WACC | 11.40% |
| Volatility Risk Premium | +21.4pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +13.4% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | -32.3% |
| Book / Price | 31.5% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 64.2% |
| FCF Margin (TTM) | -25.2% |
| Debt / Equity | 0.15 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $19.40 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $18.81 |
| Bollinger Width / SMA20 | 108.8% (drives anchor stability) |
| Net Debt | $-0.2B |
| Market Cap | $1B |
Peers used for multiples: DXCM, GEHC, IRTC, ISRG, PODD, RMD, SYK, ZBH
60-Day Conviction
82%
20-Day Fair Value
≈ by Dec 1, 2026
$19.33
α +0.7%
rank 89%
conviction
48%
40-Day Fair Value
≈ by Dec 30, 2026
$19.56
α +1.9%
rank 88%
conviction
60%
60-Day Fair Value
≈ by Jan 28, 2027
$19.80
α +3.1%
rank 86%
conviction
82%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 28.2× · 7 peers |
| Peer EV/EBITDA | n/a | 0% | median 18.5× · 8 peers |
| Peer P/B | $38.84 | 19% | median 6.4× · 8 peers |
| Peer P/S | $32.12 | 19% | median 4.9× · 8 peers |
| Market Anchor (SMA50) | $19.40 | 61% | stability 61% (BB-width) |
| Options Expected (B-L 30d) | $18.99 | 0% | 8 strikes · skew +0.01 |
As of 2026-11-02 · updated
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $1.1B
- Employees
- 888
- List Date
- 2021-09-15
- CIK
- 0001588978
- Next Earnings
- 2026-11-04 (After-Close)
- EPS Forecast
- ($0.39)
- Headquarters
- San Jose, CA
- Homepage
- https://www.procept-biorobotics.com
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -26.89% | -1.69% | 11.73% | -12.82% | -5.85% | -7.10% |
| Feb | -- | 31.75% | -4.29% | 1.98% | -9.70% | -22.13% | -0.48% |
| Mar | -- | 34.37% | -24.90% | 0.73% | -3.86% | -3.44% | 0.58% |
| Apr | -- | 0.25% | -4.01% | 12.72% | -5.45% | -5.21% | -0.34% |
| May | -- | 5.47% | 6.90% | 9.55% | 9.74% | 6.90% | 7.71% |
| Jun | -- | -18.72% | 8.80% | -6.80% | -0.59% | -18.95% | -7.25% |
| Jul | -- | 22.21% | -2.88% | 2.34% | -14.25% | -20.43% | -2.60% |
| Aug | -- | 5.97% | 0.56% | 27.42% | -19.60% | 15.34% | 5.94% |
| Sep | -9.04% | 2.67% | -3.95% | 6.74% | -9.81% | -12.86% | -4.38% |
| Oct | 10.24% | 7.10% | -15.33% | 18.11% | -2.02% | 12.81% | 5.15% |
| Nov | -23.35% | -6.92% | 34.56% | 3.58% | -8.20% | --* | -0.07% |
| Dec | -26.09% | -9.50% | 12.18% | -16.22% | 3.45% | -- | -7.24% |
| Total | -43.19% | 33.43% | -5.42% | 88.45% | -54.83% | -47.55% | -4.85% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $18.81
SMA 50: $19.40
SMA 200: $23.32
Current: $19.20
EMA 12: $19.37
EMA 26: $19.09
MACD: 0.2703 | Signal: 0.2026
BULLISH
ADX (14): 20.97
WEAK TREND
+DI: 24.19
−DI: 18.71
Momentum Oscillators
RSI (14): 50.72
NEUTRAL
Stoch %K: 79.30
Stoch %D: 85.96
Williams %R: -46.23
Volume & Volatility
BB Upper: $20.73
BB Lower: $16.88
NEUTRAL
OBV: -61,539,687
Vol SMA 20: 1,098,493
Vol ROC: -28.58%
ATR: $1.01
True Range: $1.47
HV 20: 65.1%
HV 30: 61.7%
HV 60: 61.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-01T00:00:00 – 2026-10-30T00:00:00
AI Analysis
PROCEPT BioRobotics Corporation (PRCT) - Stock Analysis Report
Executive Summary
Overall Assessment: BEARISH | Confidence Level: 8/10
Investment Thesis: PROCEPT BioRobotics faces a severe near-term headwind from multiple active securities class action lawsuits that dominate recent news flow and likely triggered the stock's decline from $24.25 (200-day MA) to $19.57. While technical indicators show some stabilization (RSI 55.82 neutral, Bollinger Bands not extreme), the bearish MACD signal (-0.47 histogram), negative alpha (-0.46), and overwhelming negative news sentiment create a high-risk environment. The stock's low beta (0.75) and defensive characteristics offer limited upside participation, but litigation risk and deteriorating fundamental signals suggest downside risks outweigh near-term recovery potential.
Key Drivers & Primary Risks:
- Litigation Risk (Critical): Six lawsuit alerts in 10-day window (Sept 19-30, 2026) signal serious securities fraud allegations and potential shareholder dilution/liability
- Technical Deterioration: Bearish MACD crossover, price trading below 50-day MA ($19.88 vs $19.57), negative OBV accumulation
- Valuation Pressure: Stock down ~19% from 200-day MA; negative alpha indicates underperformance vs risk-adjusted baseline
Recent News Sentiment Impact: 100% negative sentiment across all headlines (6/6 negative). Lawsuit alerts appear timed around mid-September (possibly earnings miss or disclosure event on 2026-08-04), creating compounding reputational and legal damage.
Technical Analysis
Trend Direction
| Timeframe | Direction | Status | |-----------|-----------|--------| | Short-term (1-4 weeks) | DOWNTREND | Price $19.57 below 50-day MA $19.88; bearish MACD; ADX 19.82 showing weak conviction | | Medium-term (1-3 months) | DOWNTREND | Price trading 19% below 200-day MA $24.25; EMA structure bearish (12 < 26) | | Long-term (3-12 months) | DOWNTREND | 200-day MA $24.25 declining; structure suggests extended bearish phase from litigation disclosure |
Support/Resistance Levels
| Level | Price | Significance | Distance | |-------|-------|--------------|----------| | Immediate Support | $18.21 | 20-day SMA (dynamic support) | -7.0% downside | | Secondary Support | $16.58 | Bollinger Band lower; psychological round number | -15.2% downside | | First Resistance | $19.84 | Bollinger Band upper; recent high | +1.4% upside | | Major Resistance | $19.88 | 50-day SMA (key moving average) | +1.6% upside | | Critical Resistance | $24.25 | 200-day SMA; pre-decline level | +24.0% upside |
Trend Assessment: Price is sandwiched between 50-day ($19.88) and 20-day ($18.21) moving averages in a compressing range, suggesting potential for sharp moves once conviction returns.
Momentum Signals
RSI (14): 55.82 — NEUTRAL
- Reading sits in middle of 30-70 range, indicating no overbought/oversold extremes
- Neither bullish nor bearish; suggests equilibrium in buyer/seller balance
- Risk: Could trend toward oversold (<30) if litigation news worsens
MACD: -0.47 (Bearish)
- Negative histogram (-0.69) indicates MACD below signal line (0.22)
- Bearish crossover confirmed: This is the primary bearish momentum signal
- EMA 12 ($18.26) below EMA 26 ($18.73) confirms negative momentum structure
- Signal: Momentum is deteriorating; no recent bullish crossover to suggest reversal
Stochastic %K: 67.97 / %D: 52.31 — OVERBOUGHT SIGNAL
- %K (67.97) significantly above %D (52.31) indicates fast momentum pulling ahead
- Reading near overbought zone without crossing 70 suggests momentum peaked but not yet exhausted
- Divergence Note: Stochastic overbought contradicts MACD bearish signal — potential early reversal setup, but requires confirmation
Bollinger Bands: NEUTRAL
- Price $19.57 sits in middle of band ($18.21 middle, width 17.92)
- Upper band $19.84 only 1.4% overhead; price near mean
- No extreme squeeze (would indicate low volatility breakout opportunity) or extreme extension
- Signal: Band position suggests mean-reversion trading environment; insufficient trend clarity
Williams %R: -7.52 — OVERBOUGHT
- Reading near -0, indicating price at upper extreme of recent range
- Conflicts with Stochastic/MACD signals, suggesting data point to monitor for divergence resolution
- Could signal exhaustion of short-term rally attempt
Volume Analysis
Volume SMA 20: 1,395,981 shares — BELOW NORMAL
- Current volume flow (implied from options volume 219 calls vs 27 puts) suggests retail interest
- Low institutional activity typical for distressed securities; institutions likely reducing exposure due to litigation
On-Balance Volume (OBV): -57,123,295 (NEGATIVE)
- Major Red Flag: Deeply negative OBV indicates sustained selling pressure and accumulation of sell orders
- OBV typically accumulates toward positive territory during rallies; large negative value suggests:
- Distribution by informed holders (early litigation disclosure awareness)
- Lack of buyer conviction
- High institutional exit flow ahead of news
Volume Rate of Change: +16.82% (ELEVATED)
- Recent volume spike 16.82% above 20-day average
- Context matters: Elevated volume on downside (given OBV negative) confirms distribution, not accumulation
- Suggests panic selling or strategic institutional unwinding
Institutional Interest Signal: Low volume and negative OBV strongly suggest institutional holders exiting positions ahead of/during litigation cascade.
News & Sentiment Analysis
Recent Headlines Summary (Last 10 Days, Sept 19-30, 2026)
Dominant Theme: Securities Class Action Lawsuits
All six headlines reference securities fraud litigation against PROCEPT:
- Shareholder Foundation Lawsuit Alert (Sept 30) — General investor notification
- Multi-Company Investigation Notice (Sept 24) — Grabar Law Office investigating PRCT along with DOCS, GDDY, PLNT
- Glancy Prongay Wolke & Rotter Lawsuit (Sept 21) — Securities fraud class action
- Kaplan Fox Investor Notification (Sept 21) — Deadline pressure (Sept 22)
- ROSEN Law Firm Class Action Lead (Sept 19) — Deadline Sept 22
- INVESTOR DEADLINE (Sept 19) — Lead plaintiff opportunity
Key Observations:
- Clustering Pattern: Multiple firms filing simultaneously (Sept 19-21) suggests a triggering event around mid-September
- Likely Catalyst: Earnings on 2026-08-04 (six weeks prior) likely contained material misstatement or guidance withdrawal
- Coordination: Multiple law firms filing suggests institutional discovery of common issue (possible accounting irregularity, FDA setback, revenue problem)
- Reputational Cascade: Each new lawsuit filing generates fresh negative headlines, amplifying stock decline
Sentiment Assessment
| Metric | Assessment | |--------|-----------| | Aggregate Sentiment | 100% NEGATIVE (6/6 negative headlines) | | Sentiment Intensity | SEVERE — Lawsuit language ("fraud," "securities," "investigation") carries maximum negative weight | | Institutional Interpretation | Signals fundamental problem, not temporary volatility | | Media Coverage Trend | Accelerating — 6 headlines in 12 days; reputational damage compounding |
Catalyst Identification
| Catalyst | Timeline | Impact | |----------|----------|--------| | Securities Fraud Litigation | IMMEDIATE (Active) | Ongoing legal risk; potential for material settlements, dilutive settlements, management liability | | Next Earnings Call | **
Generated
News
All PRCT news →
Earnings History
14 of 16 under expected move
Avg Expected Move
18.89%
Avg Actual Move
9.49%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2023-01-09 | After-Close | 11.52% | 4.93% | 0.43x | Within |
| 2023-02-28 | After-Close | 9.48% | 0.97% | 0.10x | Within |
| 2023-04-27 | After-Close | 22.96% | 13.82% | 0.60x | Within |
| 2023-07-27 | After-Close | 17.36% | 0.44% | 0.03x | Within |
| 2023-11-01 | After-Close | 17.97% | 18.37% | 1.02x | Exceeded |
| 2024-02-27 | After-Close | 19.11% | 2.68% | 0.14x | Within |
| 2024-05-01 | After-Close | 10.36% | 1.86% | 0.18x | Within |
| 2024-08-01 | After-Close | 27.74% | 7.45% | 0.27x | Within |
| 2024-10-28 | Pre-Market | 23.70% | 32.33% | 1.36x | Exceeded |
| 2025-02-25 | After-Close | 21.05% | 8.61% | 0.41x | Within |
| 2025-04-24 | Pre-Market | 20.38% | 5.64% | 0.28x | Within |
| 2025-08-06 | After-Close | 14.61% | 13.35% | 0.91x | Within |
| 2025-11-04 | After-Close | 23.27% | 9.74% | 0.42x | Within |
| 2026-02-25 | After-Close | 21.10% | 15.12% | 0.72x | Within |
| 2026-04-29 | After-Close | 21.65% | 10.73% | 0.50x | Within |
| 2026-08-04 | After-Close | 19.97% | 5.80% | 0.29x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
PRCT Options Activity & IV Rank
PRCT IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 87.1%
7-DTE IV: 91.2%
Expected Move: $3.53
7-DTE Move: $3.53
Days to Exp: 21 (2026-11-20)
Options Flow
Call Volume: 152
Put Volume: 52
P/C Volume: 0.342
BULLISH
Call OI: 835
Put OI: 273
P/C OI: 0.327
Total OI: 1,108
ATM Options Pricing
ATM Call: $1.45
ATM Put: $2.08
Call %: 7.6%
Put %: 10.8%
Chain Summary
Chain Volume: 1,158
Chain OI: 6,701
Last Updated: 10/30/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 54th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
54%
vs own history
GEX tilt
+0.27
OI-weighted, today
Vanna tilt
+0.43
δ-sensitivity to IV
Charm tilt
-0.75
δ-decay vs time
Vanna tilt +0.43: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.75: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 8 ATM contracts, 1k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 30 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 30 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)33.9MediumOct 30
IV Rank (30 DTE)66.3MediumOct 30
Straddle Price (30 DTE)$3.53Oct 30
Beta Analysis
Risk Metrics
Beta: 0.7491
Alpha: -45.87%
Correlation: 0.1470
R-Squared: 2.2%
Stock Volatility: 65.2%
Market Volatility: 12.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own PRCT
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $14.1M | #1354 of 3716 | -37.9% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $7.1M | #829 of 4729 | +4.9% | 13F | |
| Citadel Hedge fund Ken Griffin | $285K | #5116 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PRCT Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 56,212,250 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
12 filers$18.20M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $7.23M | 39.73% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $2.84M | 15.60% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $2.12M | 11.66% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $1.09M | 6.00% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $1.09M | 6.00% | 2026-06-30 |
| 6 | PEAK6 LLC | $1.07M | 5.88% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $790.30K | 4.34% | 2026-06-30 |
| 8 | Wolverine Trading, LLC Custodian | $678.71K | 3.73% | 2025-09-30 |
| 9 | Two Sigma Investments, LP Custodian | $440.31K | 2.42% | 2026-06-30 |
| 10 | Cubist Systematic Strategies, LLC | $403.30K | 2.22% | 2025-09-30 |
| 11 | Walleye Trading LLC | $248.38K | 1.36% | 2026-06-30 |
| 12 | Walleye Capital LLC | $191.93K | 1.05% | 2026-06-30 |
9 filers$5.76M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $1.44M | 24.95% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $1.34M | 23.27% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $1.09M | 18.84% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $1.00M | 17.43% | 2026-06-30 |
| 5 | Two Sigma Investments, LP Custodian | $383.86K | 6.66% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $223.54K | 3.88% | 2026-06-30 |
| 7 | Cubist Systematic Strategies, LLC | $214.14K | 3.71% | 2025-09-30 |
| 8 | Walleye Capital LLC | $42.90K | 0.74% | 2026-06-30 |
| 9 | GROUP ONE TRADING LLC Custodian | $29.35K | 0.51% | 2026-06-30 |
PRCT Insider Trading (Form 4)
Latest: 2026-10-05Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Michael Mack | Director | Award (A) | +7,727 | — | EDGAR | |
| 2026-09-10 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −297 | $20.95 | -$6.2K | EDGAR |
| 2026-09-10 | Kevin Waters | EVP, CFO | Sell (S) | −373 | $20.95 | -$7.8K | EDGAR |
| 2026-09-10 | Barry L Templin | EVP, Chief Technology Officer | Sell (S) | −373 | $20.95 | -$7.8K | EDGAR |
| 2026-08-14 | Pooja Sharma | Chief Strat/Marketing Officer | Award (A) | +23,622 | — | EDGAR | |
| 2026-08-14 | Kevin Waters | EVP, CFO | Award (A) | +29,527 | — | EDGAR | |
| 2026-08-14 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Award (A) | +22,965 | — | EDGAR | |
| 2026-08-14 | Barry L Templin | EVP, Chief Technology Officer | Award (A) | +26,246 | — | EDGAR | |
| 2026-08-10 | Larry L Wood | President, CEO | Buy (P) | +23,900 | $20.85 | $498.3K | EDGAR |
| 2026-06-10 | Barry L Templin | EVP, Chief Technology Officer | Sell (S) | −358 | $28.48 | -$10.2K | EDGAR |
| 2026-06-10 | Kevin Waters | EVP, CFO | Sell (S) | −357 | $28.48 | -$10.2K | EDGAR |
| 2026-06-10 | Antal Rohit Desai | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Thomas M Prescott | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Elisabeth Sandoval Little | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −285 | $28.48 | -$8.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
PRCT Insider Holdings
16 insiders · @ $19.20
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Frederic H Moll | Director | 866,474 | $16.64M | $7.72M | 9 | 2026-06-10 |
| 2 | Antal Rohit Desai | Director | 463,429 | $8.90M | -$14.65M | 20 | 2026-06-10 |
| 3 | Larry L Wood | President, CEO | 338,103 | $6.49M | $498.3K | 6 | 2026-08-10 |
| 4 | Reza Zadno | President, CEO | 186,829 | $3.59M | -$38.48M | 20 | 2025-05-13 |
| 5 | Kevin Waters | EVP, CFO | 180,355 | $3.46M | -$13.24M | 25 | 2026-09-10 |
| 6 | Taylor C. Harris | Director | 137,565 | $2.64M | $250.0K | 7 | 2026-06-10 |
| 7 | Alaleh Nouri | EVP, CLO, CORP. SEC. | 127,737 | $2.45M | -$10.85M | 30 | 2026-09-10 |
| 8 | Pooja Sharma | Chief Strat/Marketing Officer | 111,181 | $2.13M | $0 | 1 | 2026-08-14 |
| 9 | Barry L Templin | EVP, Chief Technology Officer | 94,826 | $1.82M | -$18.0K | 3 | 2026-09-10 |
| 10 | Hisham Shiblaq | EVP, Chief Comm. Officer | 70,837 | $1.36M | -$5.06M | 12 | 2025-06-06 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
PRCT Board & Officers
As of SEC filings through Oct 5, 2026Directors 10
- Amy M. Dodrill · since Sep 14, 2021
- Antal Rohit Desai · since Sep 14, 2021
- Frederic H Moll · since Sep 14, 2021
- Taylor C. Harris · since Sep 14, 2021
- Elisabeth Sandoval Little · on file since Oct 2021
- Mary Garrett · on file since Jan 2022
- Larry L Wood · on file since Apr 2024
- Thomas M Prescott · on file since Jul 2024
- Dan Puckett · since Mar 5, 2026
- Michael Mack · since Oct 2, 2026
Officers 6
- Larry L Wood · President, CEO · listed since Sep 2025
- Kevin Waters · EVP, CFO · listed since Apr 2022
- Hisham Shiblaq · EVP, Chief Comm. Officer · listed since Apr 2022
- Barry L Templin · EVP, Chief Technology Officer · since Apr 16, 2026
- Pooja Sharma · Chief Strat/Marketing Officer · since Apr 16, 2026
- Alaleh Nouri · EVP, CLO, Corp. Sec. · listed since Apr 2022
Changes in the last 10 years (43)
| Oct 2, 2026 | Michael Mack became a director |
| Apr 16, 2026 | Pooja Sharma became Chief Strat/Marketing Officer |
| Apr 16, 2026 | Barry L Templin became EVP, Chief Technology Officer |
| Mar 5, 2026 | Dan Puckett became a director |
| Sep 4, 2025 | Larry L Wood first listed as President, CEO in an SEC filing |
| Jul 23, 2025 | The company announced the departure of Reza Zadno from the board in an SEC filing |
| Jul 23, 2025 | The company announced the departure of Reza Zadno as President, CEO in an SEC filing |
| Sep 5, 2024 | Antal Rohit Desai no longer listed as a 10% owner in SEC filings |
| Jul 19, 2024 | Thomas M Prescott first on file as a director |
| Jul 18, 2024 | The company announced the departure of Thomas M Krummel from the board in an SEC filing |
| May 7, 2024 | White Tailed Ptarmigan, LP reported in an SEC filing no longer being a 10% owner |
| May 7, 2024 | R Kent McGaughy Jr reported in an SEC filing no longer being a 10% owner |
| May 7, 2024 | CPMG Inc reported in an SEC filing no longer being a 10% owner |
| Apr 19, 2024 | Larry L Wood first on file as a director |
| Apr 4, 2022 | Kevin Waters listed as EVP, CFO (previously Senior VP, CFO) in SEC filings |
| Apr 4, 2022 | Hisham Shiblaq listed as EVP, Chief Comm. Officer (previously SVP, Commercial Operations) in SEC filings |
| Apr 4, 2022 | Alaleh Nouri listed as EVP, CLO, Corp. Sec. (previously SVP, Gen Counsel, Corp. Sec.) in SEC filings |
| Mar 22, 2022 | Viking Global Opportunities Parent GP LLC first on file as a 10% owner |
| Jan 3, 2022 | Mary Garrett first on file as a director |
| Oct 25, 2021 | Elisabeth Sandoval Little first on file as a director |
| Sep 21, 2021 | Dragsa 88 LLC first on file as a 10% owner |
| Sep 16, 2021 | Antal Rohit Desai first listed as a 10% owner in an SEC filing |
| Sep 14, 2021 | White Tailed Ptarmigan, LP became a 10% owner |
| Sep 14, 2021 | Viking Global Opportunities Portfolio GP LLC became a 10% owner |
| Sep 14, 2021 | Viking Global Opportunities Illiquid Investments Sub-Master LP became a 10% owner |
| Sep 14, 2021 | Viking Global Opportunities GP LLC became a 10% owner |
| Sep 14, 2021 | Viking Global Investors LP became a 10% owner |
| Sep 14, 2021 | Thomas M Krummel became a director |
| Sep 14, 2021 | Taylor C. Harris became a director |
| Sep 14, 2021 | Rose Sharon Shabet became a 10% owner |
| Sep 14, 2021 | Reza Zadno became a director |
| Sep 14, 2021 | Reza Zadno became President, CEO |
| Sep 14, 2021 | R Kent McGaughy Jr became a 10% owner |
| Sep 14, 2021 | Ole Andreas Halvorsen became a 10% owner |
| Sep 14, 2021 | Morgan Colby Wood became a director |
| Sep 14, 2021 | Kevin Waters became Senior VP, CFO |
| Sep 14, 2021 | Hisham Shiblaq became SVP, Commercial Operations |
| Sep 14, 2021 | Frederic H Moll became a director |
| Sep 14, 2021 | David C. Ott became a 10% owner |
| Sep 14, 2021 | CPMG Inc became a 10% owner |
| Sep 14, 2021 | Antal Rohit Desai became a director |
| Sep 14, 2021 | Amy M. Dodrill became a director |
| Sep 14, 2021 | Alaleh Nouri became SVP, Gen Counsel, Corp. Sec. |
Not reported recently (10)
- Morgan Colby Wood · Last reported as a director in an SEC filing dated Nov 14, 2023
- Viking Global Opportunities GP LLC · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Viking Global Opportunities Portfolio GP LLC · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Viking Global Investors LP · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Ole Andreas Halvorsen · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- David C. Ott · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Rose Sharon Shabet · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Viking Global Opportunities Illiquid Investments Sub-Master LP · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Dragsa 88 LLC · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
- Viking Global Opportunities Parent GP LLC · Last reported as a 10% owner in an SEC filing dated Mar 22, 2022
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
PRCT Proposed Insider Sales (Form 144)
Latest: 2026-09-09
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
3 filings
· $22K notice value
· 3 unique filers
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-09 | Nouri Alaleh | Officer | 297 | $6.2K | 2026-09-09 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-09 | Templin Barry L | Officer | 373 | $7.8K | 2026-09-09 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-09 | Waters Kevin | Officer | 373 | $7.8K | 2026-09-09 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-08 | Nouri Alaleh | Officer | 285 | $8.1K | 2026-06-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-08 | Waters Kevin | Officer | 357 | $10.2K | 2026-06-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-08 | Templin Barry L | Officer | 358 | $10.2K | 2026-06-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-19 | Alalah Nouri | Officer | 5,363 | $140.3K | 2026-03-19 | J.P. Morgan Securities LLC | 10b5-1 | EDGAR |
| 2026-03-17 | Nouri Alaleh | Officer | 304 | $8.6K | 2026-03-17 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-17 | Waters Kevin | Officer | 706 | $19.9K | 2026-03-17 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-03-10 | Alalah Nouri | Officer | 3,243 | $81.9K | 2026-03-10 | J.P. Morgan Securities LLC | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
59 ETFs hold PRCT
25 shown · $162.36M total exposure · 0.03% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $31.1M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.04% | $27.1M | $75.5B | 2026-10-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.01% | $22.3M | — | 2026-09-30 |
| 4 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.03% | $12.4M | — | 2026-09-30 |
| 5 | VXF Vanguard Extended Market ETF | Vanguard | 0.01% | $11.8M | — | 2026-09-30 |
| 6 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.07% | $10.2M | $14.0B | 2026-10-30 |
| 7 | BOTZ Global X Robotics & Artificial Intelligence ETF | Global X | 0.30% | $9.1M | — | 2026-10-30 |
| 8 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.03% | $7.1M | — | 2026-05-31 |
| 9 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.03% | $5.9M | — | 2026-09-30 |
| 10 | IHI iShares U.S. Medical Devices ETF | iShares (BlackRock) | 0.15% | $5.3M | $3.7B | 2026-10-30 |
| 11 | VHT Vanguard Health Care ETF | Vanguard | 0.01% | $3.0M | — | 2026-09-30 |
| 12 | KOMP State Street® SPDR® S&P Kensho New Economies Composite ETF | SPDR (State Street) | 0.11% | $2.8M | $2.6B | 2026-10-29 |
| 13 | XHE State Street® SPDR® S&P® Health Care Equipment ETF | SPDR (State Street) | 1.48% | $2.3M | $156.9M | 2026-10-29 |
| 14 | FYC First Trust Small Cap Growth AlphaDEX® Fund | First Trust | 0.13% | $1.8M | $1.3B | 2026-10-30 |
| 15 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $1.5M | $95.5B | 2026-10-30 |
| 16 | FSCC Federated Hermes MDT Small Cap Core ETF | Nport | 0.39% | $1.4M | — | 2026-08-31 |
| 17 | ESML iShares ESG Aware MSCI USA Small-Cap ETF | iShares (BlackRock) | 0.05% | $1.3M | $2.7B | 2026-10-30 |
| 18 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.07% | $1.1M | — | 2026-09-30 |
| 19 | NUSC Nuveen ESG Small-Cap ETF | Nport | 0.07% | $947,907 | — | 2026-07-31 |
| 20 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $916,969 | — | 2026-05-31 |
| 21 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.01% | $726,192 | — | 2026-10-29 |
| 22 | FHLC Fidelity MSCI Health Care Index ETF | Fidelity | 0.01% | $566,451 | $3.9B | 2026-10-29 |
| 23 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $526,643 | — | 2026-10-29 |
| 24 | ONEQ Fidelity Nasdaq Composite Index ETF | Fidelity | 0.00% | $524,308 | $10.8B | 2026-10-29 |
| 25 | RSSL Global X Russell 2000 ETF | Global X | 0.04% | $522,240 | — | 2026-10-30 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-1.94
TTM Revenue
$337.34M
TTM Net Income
$-109.75M
TTM Op. Cash Flow
$-74.34M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $94.50M | $-26.86M | $-0.47 | $-19.25M |
| Q1 '26 | 2026-03-31 | $83.13M | $-31.64M | $-0.56 | $-38.13M |
| Q4 '25 | 2025-12-31 | $76.38M | $-29.84M | $-0.53 | $-10.33M |
| Q3 '25 | 2025-09-30 | $83.33M | $-21.41M | $-0.38 | $-6.63M |
| Q2 '25 | 2025-06-30 | $79.18M | $-19.58M | $-0.35 | $-15.04M |
| Q1 '25 | 2025-03-31 | $69.16M | $-24.74M | $-0.45 | $-16.98M |
| Q4 '24 | 2024-12-31 | $68.24M | $-18.86M | $-0.34 | $-32.39M |
| Q3 '24 | 2024-09-30 | $58.37M | $-20.97M | $-0.40 | $-18.80M |
| Q2 '24 | 2024-06-30 | $53.35M | $-25.63M | $-0.50 | $-15.74M |
| Q1 '24 | 2024-03-31 | $44.54M | $-25.96M | $-0.51 | $-32.29M |
| Q4 '23 | 2023-12-31 | $43.58M | $-27.50M | $-0.54 | $-24.79M |
| Q3 '23 | 2023-09-30 | $35.10M | $-24.62M | $-0.51 | $-18.94M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
3.17
P/S
3.20
EV/EBITDA
—
EV/Sales
2.68
ROE
-32.3%
ROA
-22.9%
Div Yield
0.00%
FCF Yield
-6.89%
Debt/Equity
0.15
Current Ratio
—
Market Cap
$1.08B
as of 2026-10-30
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
7.50M
SI % of Float
14.09%
Days to Cover
5.57
Short Vol Ratio
44.2%
Free Float
53.23M
Float %
92.9%
Short interest 2026-10-15 • Short volume 2026-10-30 • Float 2026-09-22